March 23, 2026

TransMedics Group, Inc. (TMDX) Stock Analysis: A 39.52% Upside Potential in Healthcare Innovation

TransMedics Group, Inc. (NASDAQ: TMDX) is carving out a significant niche within the medical devices sector, specifically targeting the transformative corner of organ transplant therapy. With..

Encompass Health Corporation (EHC) Stock Analysis: Potential 48.89% Upside Beckons Investors

Investors seeking opportunities in the healthcare sector might find Encompass Health Corporation (NYSE: EHC) a compelling prospect. With a market capitalization of $9.65 billion, this Birmingham,..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A 46.83% Potential Upside Sparks Investor Interest

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a pioneering player in the biotechnology sector, is capturing investor attention with its potential 46.83% upside, as indicated by its average..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A 216% Upside Potential in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company based in Redwood City, California, has captured the attention of investors in the biotechnology sector. With a market..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 52% Upside Potential in Healthcare Tech

As investors navigate the expansive healthcare sector, Waystar Holding Corp. (NASDAQ: WAY) emerges as a noteworthy contender, driven by its robust technology solutions for healthcare payments...

Halozyme Therapeutics (HALO) Stock Analysis: A Biotech Powerhouse with 33% Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a frontrunner in the biotechnology sector, is garnering significant attention from investors due to a remarkable 33.22% potential upside, as indicated..

Oscar Health, Inc. (OSCR) Stock Analysis: A Healthcare Player with a 21.93% Upside Potential

Oscar Health, Inc. (NYSE: OSCR), a key player in the U.S. healthcare plans sector, is drawing attention from investors with its innovative approach and a notable..

Cytokinetics, Inc. (CYTK) Stock Analysis: Exploring a 48.57% Potential Upside in the Biotech Arena

Investors with a keen eye on the biotechnology sector should take a closer look at Cytokinetics, Incorporated (NASDAQ: CYTK), a biopharmaceutical company carving a niche in..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Unlocking an 18.59% Upside in Eye Health Innovation

In the ever-evolving landscape of healthcare, Bausch + Lomb Corporation (NYSE: BLCO) stands as a beacon of innovation and expertise within the medical instruments and supplies..

Natera, Inc. (NTRA) Stock Analysis: Potential 33% Upside with Robust Revenue Growth

Natera, Inc. (NASDAQ: NTRA), a healthcare leader in diagnostics and research, presents a compelling opportunity for investors. With a market cap of $27.68 billion, Natera specializes..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unveiling a 22.5% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Bio-Rad Laboratories, Inc. (BIO) presents an intriguing proposition. With a market capitalization of $7.14 billion, Bio-Rad operates at..

BrightSpring Health Services (BTSG) Stock Analysis: 27.64% Potential Upside with Strong Buy Ratings

BrightSpring Health Services, Inc. (BTSG) is capturing investor attention with its robust growth trajectory and the solid backing of analyst ratings. Operating within the healthcare sector,..

Bruker Corporation (BRKR) Stock Analysis: Exploring a Potential 45% Upside

Bruker Corporation (NASDAQ: BRKR), a prominent player in the medical devices industry, is attracting attention from investors seeking opportunities in the healthcare sector. Headquartered in Billerica,..

Chemed Corp (CHE) Stock Analysis: Navigating a 17.20% Potential Upside in the Healthcare Sector

Chemed Corp (NYSE: CHE), a key player in the United States healthcare sector, particularly within the medical care facilities industry, presents an intriguing proposition for investors..

Atrium Therapeutics, Inc. (RNA): Investor Outlook on a Potential 90% Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA), a burgeoning name in the biotechnology sector, is capturing investor attention with its promising pipeline focused on RNA therapeutics for cardiomyopathies...

Corcept Therapeutics (CORT) Stock Analysis: Exploring an 88.80% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, has caught the eye of investors with its substantial potential upside of 88.80%. Headquartered..

Guardant Health, Inc. (GH)

⚠️ No article content returned.

..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Navigating a 19.57% Potential Upside in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a stalwart in the healthcare sector specializing in diagnostic and therapeutic products, presents an intriguing opportunity for investors seeking to capitalize..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a Potential 33.87% Upside

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, continues to capture investor attention with its robust operational framework and a potential..

argenx SE (ARGX) Stock Analysis: Potential Upside Sparks Investor Interest

argenx SE (NASDAQ: ARGX), a leader in the biotechnology sector, stands out with a compelling growth narrative and strong investor interest. Specializing in therapies for autoimmune..

Search

Funds

March 23, 2026

Search

Funds

March 23, 2026

FTSE 100

Funds